Pharmacy Disclosure Log 2025

1. Asthma Response 1003
2. Asthma Response 1003 Attachment
3. Atopic Dermatitis Response 981
4. Biologics Rheumatology Response 1057
5. Biologics - Dermatology Response 1046
6. Biologic Medicines in Gastroenterology Response 847
7. Biologics Gastro Response 1128
8. Biologics Rheumatology Response 762
9. Blood Cultures Response 940
10. Bruxism Data Response 1134
11. Curosurf and Peyona Response 1110
12. Dermatology and Respiratory Medicine Response 977
13. Dermatology Response 771
14. Diffuse Large B Cell Lymphoma Response 827
15. Endometrial Cancer Response 923
16. Eosinophilic Oesophagitis (EoE) Response 972
17. Elastomeric Infusion Devices Response 1031
18. Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and Blood Products Response 772
19. Fibrinogen Concentrate, Prothrombin Complex Concentrate, DOAC Antidote, and blood Products Response 772 Attachment
20. Formularies and Committees Response 941
21. Friedreich Ataxia Response 921
22. Gastroenterology Response 1156
23. Giant Cell Arteritis Response 1083
24. Human Albumin Response 826
25. Immunoglobulin Treatment Response 932
26. Intra-Vitreal Injections Implants Response 810
27. Intra-vitreal treatments Response 870
28. Intra-Vitreal Injections or Implants Response 1066
29. Intra-Vitreal Treatments Response 1145
30. Lung Cancer Response 1148
31. Lung Cancer Response 864
32. Lung Cancer Response 864 Attachment
33. Medication errors Rocuronium Response 918
34. Melanoma Response 901
35. Migraine Response 856
36. Migraine Response 1138
37. Multiple Myeloma Response 1015
38. Multiple Sclerosis Response 1079
39. Multiple Sclerosis Response 1079 - Attachment
40. New Biologic and Targeted Medications Response 867
41. Non-Medical uses of Blood Response 802
42. NHS Pharmacy Aseptic Services Response 803
43. Oncology Breast Cancer Response 1118
44. Oncology Response 1146
45. Oncology Breast Cancer Response 857
46. Oncology Response 928
47. Orthopaedic Antibiotic Guidelines for Open Fractures, Closed Trauma, and Elective Surgery Response 1155
48. Orthopaedic Antibiotic Guidelines for Open Fractures, Closed Trauma, and Elective Surgery Response 1155 - Attachment
49. Ovarian Cancer Response 944
50. Pancreatic Enzyme Replacement Therapy (PERT) Response 1114
51. Patients treated with Ruxolitinib Response 933
52. Patients treated with Ruxolitinib Response 933 Attachment
53. Prescription CBPMs Response 998
54. Prescription CBPMs Response 998 - Attachment
55. Primary Diagnosis of GCA Response 784
56. Prostate Cancer Patient Response 984
57. Renal Cell Carcinoma Response 871
58. Renal Cell Carcinoma Response 871 Attachment
59. Social Prescribing Response 1021
60. Sodium Chloride and Levofloxacin in Ophthalmology Response 994
61. Spinal Muscular Atrophy Response 794
62. Spinal Muscular Atrophy Response 1078
63. Spinal Muscular Atrophy Response 1078 - Attachment
64. Treatment of Insomnia Response 1109
65. Treatment of Breast Cancer Response 1112
66. Treatment of Breast Cancer Response 1112 - Attachment
67. Trust Processes to Reduce Medication Waste Response 885
68. Urothelial Cancer Response 930
69. Wound Formulary Response 860